Showing results (181-190 of 340) with videos related to

Sort By:
Pageof 34
The Lancet. Diabetes & Endocrinology|August 14, 2015
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trialDick de Zeeuw, Pirow Bekker, Elena Henkel, et al.
Journal of Hypertension|October 14, 2004
Does comorbidity explain trends in prescribing of newer antihypertensive agents?Jacoba P Greving, Petra Denig, Willem Jan van der Veen, et al.
Hypertension (Dallas, Tex. : 1979)|February 18, 2004
C-reactive protein modifies the relationship between blood pressure and microalbuminuriaErik M Stuveling, Stephan J L Bakker, Hans L Hillege, et al.
Endocrinology, Diabetes & Metabolism|July 19, 2021
Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS ProgramKatherine M Wang, JingWei Li, Vivek Bhalla, et al.
European Journal of Pharmacology|November 27, 2007
Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized ratsWillemijn A K M Windt, Richard P E van Dokkum, C Alex Kluppel, et al.
Diabetes Care|July 21, 2012
Growth-differentiation factor 15 predicts worsening of albuminuria in patients with type 2 diabetesMerel E Hellemons, Magdalena Mazagova, Ron T Gansevoort, et al.
Kidney International|May 23, 2008
Gender differences in predictors of the decline of renal function in the general populationNynke Halbesma, Auke H Brantsma, Stephan J L Bakker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 5, 2011
Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) databaseDavid K Packham, Tahira P Alves, Jamie P Dwyer, et al.
Diabetes|March 29, 2014
Bilirubin and progression of nephropathy in type 2 diabetes: a post hoc analysis of RENAAL with independent replication in IDNTIneke J Riphagen, Petronella E Deetman, Stephan J L Bakker, et al.
European Journal of Preventive Cardiology|November 6, 2013
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trialHiddo J Lambers Heerspink, Peggy Gao, Dick de Zeeuw, et al.
Pageof 34